{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:25:33Z","timestamp":1780471533942,"version":"3.54.1"},"reference-count":146,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.clindermatol.2017.08.004","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T23:46:19Z","timestamp":1501890379000},"page":"530-540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Vasculitis: Kids are not just little people"],"prefix":"10.1016","volume":"35","author":[{"given":"Nikita","family":"Lakdawala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Fedeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2017.08.004_bb0005","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.clindermatol.2006.07.007","article-title":"Cutaneous vasculitis: Diagnosis and management","volume":"24","author":"Carlson","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archderm.134.3.309","article-title":"Prognostic factors in leukocytoclastic vasculitis: A clinicopathologic study of 160 patients","volume":"134","author":"Sais","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archderm.1997.03890400041006","article-title":"Adhesion molecule expression and endothelial cell activation in cutaneous leukocytoclastic vasculitis. An immunohistologic and clinical study in 42 patients","volume":"133","author":"Sais","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.pcl.2013.11.007","article-title":"Diagnosis and management of cutaneous vasculitis in children","volume":"61","author":"Ting","year":"2014","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0025","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1517\/14740338.4.5.837","article-title":"Risk of skin reactions when using ibuprofen-based medicines","volume":"4","author":"Sanchez-Borges","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0030","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(02)11279-7","article-title":"Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins","volume":"360","author":"Gardner-Medwin","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0035","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.autrev.2014.01.031","article-title":"The diagnosis and classification of Henoch-Schonlein purpura: An updated review","volume":"13","author":"Yang","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0040","first-page":"248","article-title":"Bullous Henoch-Schonlein purpura in children","volume":"96","author":"Chen","year":"2015","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0045","first-page":"769","article-title":"Indications and limitations of histopathological skin investigation of Henoch-Schonlein purpura in children","volume":"53","author":"Murgu","year":"2012","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00063030-200115020-00004","article-title":"Schonlein-henoch purpura in children and adults: Diagnosis, pathophysiology and management","volume":"15","author":"Rostoker","year":"2001","journal-title":"BioDrugs"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0055","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.dad.0000181109.54532.c5","article-title":"Cutaneous vasculitis update: Diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis","volume":"27","author":"Carlson","year":"2005","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0060","first-page":"1968","article-title":"Pediatric rheumatology clinic populations in the United States: Results of a 3 year survey. Pediatric Rheumatology Database Research Group","volume":"23","author":"Bowyer","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.semarthrit.2005.08.007","article-title":"Henoch Schonlein purpura in childhood: Epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature","volume":"35","author":"Trapani","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0070","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.berh.2004.11.006","article-title":"What is known about the epidemiology of the vasculitides?","volume":"19","author":"Watts","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/BOR.0b013e32835d8e2a","article-title":"Epidemiology of immunoglobulin A vasculitis (Henoch-Schonlein): Current state of knowledge","volume":"25","author":"Piram","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0080","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.autrev.2015.02.003","article-title":"IgA vasculitis (Henoch-Shonlein purpura) in adults: Diagnostic and therapeutic aspects","volume":"14","author":"Audemard-Verger","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0085","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/sarh.2002.33980","article-title":"Henoch-Schonlein purpura in children and adults: Clinical differences in a defined population","volume":"32","author":"Garcia-Porrua","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0090","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.autrev.2013.04.003","article-title":"Is there a crossroad between infections, genetics, and Henoch-Schonlein purpura?","volume":"12","author":"Rigante","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0095","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5414\/CNP60080","article-title":"Outcome of Henoch-Schoenlein nephritis with nephrotic-range proteinuria","volume":"60","author":"Ronkainen","year":"2003","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0100","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/adc.2005.074641","article-title":"Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: A systematic review","volume":"90","author":"Narchi","year":"2005","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0105","first-page":"S26","article-title":"Henoch-Schonlein\u2019s purpura in adults versus children\/adolescents: A comparative study","volume":"24","author":"Uppal","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0110","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/art.1780400513","article-title":"Henoch-Schonlein purpura in adulthood and childhood: Two different expressions of the same syndrome","volume":"40","author":"Blanco","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0115","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/01.ASN.0000013883.99976.22","article-title":"Henoch-Sch\u00f6nlein purpura in adults: Outcome and prognostic factors","volume":"13","author":"Pillebout","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0120","first-page":"259","article-title":"Renal involvement in Henoch-Schonlein purpura: A multivariate analysis of initial prognostic factors","volume":"83","author":"de Almeida","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0125","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-005-1903-z","article-title":"Renal manifestations in Henoch-Schonlein purpura: A 10-year clinical study","volume":"20","author":"Chang","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0130","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/ndt\/12.11.2277","article-title":"Long-term prognosis of Henoch-Sch\u00f6nlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Sch\u00f6nlein purpura","volume":"12","author":"Coppo","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/qjmed\/hcl034","article-title":"Henoch Sch\u00f6nlein purpura with nephritis in adults: Adverse prognostic indicators in a UK population","volume":"99","author":"Shrestha","year":"2006","journal-title":"QJM"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/sarh.2002.37322","article-title":"Henoch Schonlein purpura in children and adults: is it one entity?","volume":"32","author":"Ilan","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0145","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/adc.2009.167874","article-title":"Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: A 6-month prospective study","volume":"95","author":"Jauhola","year":"2010","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00861574","article-title":"Corticosteroid therapy does not prevent nephritis in Henoch-Schonlein purpura","volume":"7","author":"Saulsbury","year":"1993","journal-title":"Pediatr Nephrol (Berlin, Germany)"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0155","first-page":"1007","article-title":"Henoch-Schonlein purpura in children: Limited benefit of corticosteroids","volume":"60","author":"Bluman","year":"2014","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0160","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/archdischild-2013-303642","article-title":"Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein purpura (HSP)","volume":"98","author":"Dudley","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1741-7015-2-7","article-title":"A randomized, placebo-controlled trial of prednisone in early Henoch Schonlein purpura [ISRCTN85109383]","volume":"2","author":"Huber","year":"2004","journal-title":"BMC Med"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0170","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/adc.2009.182394","article-title":"Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children","volume":"95","author":"Jauhola","year":"2010","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0175","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jpeds.2006.03.024","article-title":"Early prednisone therapy in Henoch-Schonlein purpura: A randomized, double-blind, placebo-controlled trial","volume":"149","author":"Ronkainen","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.ASN.0000103869.08096.4F","article-title":"Corticosteroid effectiveness in IgA nephropathy: Long-term results of a randomized, controlled trial","volume":"15","author":"Pozzi","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0185","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s00467-008-1066-9","article-title":"Treatment-based literature of Henoch-Schonlein purpura nephritis in childhood","volume":"24","author":"Zaffanello","year":"2009","journal-title":"Pediatr Nephrol (Berlin, Germany)"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0190","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00467-005-1869-x","article-title":"Can azathioprine and steroids alter the progression of severe Henoch-Schonlein nephritis in children?","volume":"20","author":"Shin","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0195","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.arcped.2011.08.011","article-title":"Dapsone for chronic skin lesions in 3 children suffering from Henoch-Schonlein vasculitis","volume":"18","author":"Mazille","year":"2011","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0200","first-page":"639","article-title":"Chronic recalcitrant Henoch-Schonlein purpura: successful treatment with dapsone","volume":"20","author":"Papandreou","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0205","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/rheumatology\/40.12.1430","article-title":"Colchicine for the treatment of recurrent Henoch-Schonlein purpura in an adult","volume":"40","author":"Pyne","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0210","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000341914","article-title":"The combination of mycophenolate mofetil with corticosteroids induces remission of Henoch-Schonlein purpura nephritis","volume":"36","author":"Ren","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0215","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5414\/CN106553","article-title":"Cyclosporin A in adult patients with Henoch-Schonlein purpura nephritis and nephrotic syndrome; 5 case reports","volume":"75","author":"Kalliakmani","year":"2011","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0220","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00467-011-1919-5","article-title":"Cyclosporine A versus methylprednisolone for Henoch-Schonlein nephritis: A randomized trial","volume":"26","author":"Jauhola","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00467-003-1315-x","article-title":"Henoch-Schonlein purpura nephritis: Course of disease and efficacy of cyclophosphamide","volume":"19","author":"Tarshish","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0230","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1651-2227.2001.tb01370.x","article-title":"Intravenous immunoglobulin therapy for severe digestive manifestations of Henoch-Schonlein purpura","volume":"90","author":"Lamireau","year":"2001","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0235","doi-asserted-by":"crossref","first-page":"476","DOI":"10.7326\/0003-4819-120-6-199403150-00005","article-title":"High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schonlein purpura","volume":"120","author":"Rostoker","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0240","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12026-016-8827-5","article-title":"Rituximab therapy for IgA-vasculitis with nephritis: A case series and review of the literature","volume":"65","author":"Fenoglio","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0245","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12969-016-0082-8","article-title":"Therapeutic advances in the treatment of vasculitis","volume":"14","author":"Eleftheriou","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0250","series-title":"Hurwitz Clinical Pediatric Dermatology: A Textbook of Skin Disorders of Childhood and Adolescence","author":"Paller","year":"2016"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0255","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1525-1470.1996.tb01186.x","article-title":"Neonatal acute hemorrhagic edema of childhood: Case report and review of the English-language literature","volume":"13","author":"Cunningham","year":"1996","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0260","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jaad.2008.06.005","article-title":"Acute hemorrhagic edema of young children (cockade purpura and edema): A case series and systematic review","volume":"59","author":"Fiore","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0265","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1525-1470.2007.00336.x","article-title":"Intussusception in an infant with acute hemorrhagic edema of infancy","volume":"24","author":"Yu","year":"2007","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0270","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/archderm.1994.01690080123021","article-title":"Targetlike lesions in an infant. Infantile acute hemorrhagic edema (AHE)","volume":"130","author":"Serna","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0275","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0091-6749(05)80202-7","article-title":"Acute hemorrhagic edema of infancy (AHEI)\u2014a variant of Henoch-Schonlein purpura or a distinct clinical entity?","volume":"86","author":"Saraclar","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0280","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/dth.12103","article-title":"Urticaria mimickers in children","volume":"26","author":"Mathur","year":"2013","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0285","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1034\/j.1600-0560.2003.00033.x","article-title":"Cutaneous vasculitis: A review","volume":"30","author":"Crowson","year":"2003","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0290","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00467-009-1327-2","article-title":"The \u201cother\u201d vasculitis syndromes and kidney involvement","volume":"25","author":"Ozen","year":"2010","journal-title":"Pediatr Nephrol (Berlin, Germany)"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0295","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5001\/omj.2013.76","article-title":"Hypocomplementemic urticarial vasculitis syndrome in an 8-year-old boy: A case report and review of literature","volume":"28","author":"Al Mosawi","year":"2013","journal-title":"Oman Med J"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0300","first-page":"756","article-title":"Hypocomplementemic urticarial vasculitis syndrome: An interdisciplinary challenge","volume":"106","author":"Grotz","year":"2009","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0305","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0190-9622(92)70069-R","article-title":"Urticarial vasculitis: A histopathologic and clinical review of 72 cases","volume":"26","author":"Mehregan","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0310","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1007\/s00296-011-2107-4","article-title":"Mycoplasma pneumoniae infection associated with urticarial vasculitis mimicking adult-onset Still\u2019s disease","volume":"32","author":"Dua","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0315","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000430809","article-title":"Unusual eruptions associated with mycoplasma pneumoniae respiratory infections: Review of the literature","volume":"231","author":"Terraneo","year":"2015","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0320","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MD.0000000000000013","article-title":"Urticarial vasculitis in northern Spain: Clinical study of 21 cases","volume":"93","author":"Loricera","year":"2014","journal-title":"Medicine"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0325","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00002281-200001000-00005","article-title":"Urticarial vasculitis","volume":"12","author":"Wisnieski","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0330","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/0378-6323.148586","article-title":"Enalapril induced normocomplementemic urticarial vasculitis","volume":"81","author":"Koregol","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0335","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0190-9622(24)00193-2","article-title":"Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis","volume":"38","author":"Davis","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0340","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1385\/CRIAI:23:2:201","article-title":"Urticarial vasculitis","volume":"23","author":"Venzor","year":"2002","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0345","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1046\/j.1365-2133.2000.03913.x","article-title":"Mycophenolate mofetil is effective for maintenance therapy of hypocomplementaemic urticarial vasculitis","volume":"143","author":"Worm","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0350","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1016\/S0190-9622(03)00744-8","article-title":"Hypocomplementemic urticarial vasculitis with angioedema, a rare presentation of systemic lupus erythematosus: Rapid response to rituximab","volume":"49","author":"Saigal","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0355","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1525-1470.2009.00950.x","article-title":"Intravenous immunoglobulin therapy for hypocomplementemic urticarial vasculitis associated with systemic lupus erythematosus in a child","volume":"26","author":"Yamazaki-Nakashimada","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0360","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/art.20033","article-title":"Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra","volume":"50","author":"Hawkins","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0365","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaad.2007.03.036","article-title":"Schnitzler syndrome: Treatment failure to rituximab but response to anakinra","volume":"57","author":"Eiling","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0370","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/11599660-000000000-00000","article-title":"A review of pediatric vasculitis with a focus on juvenile polyarteritis nodosa","volume":"13","author":"Kawakami","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0375","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1067\/mjd.2003.212","article-title":"Cutaneous vasculitis","volume":"48","author":"Fiorentino","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0380","first-page":"831","article-title":"Juvenile polyarteritis: Is it a different disease?","volume":"31","author":"Ozen","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0385","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/ard.54.2.134","article-title":"Benign cutaneous polyarteritis nodosa in children below 10 years of age\u2014a clinical experience","volume":"54","author":"Kumar","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0390","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.mpg.0000235753.37358.72","article-title":"Gastrointestinal involvement in pediatric polyarteritis nodosa","volume":"44","author":"de Carpi","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0395","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jpeds.2004.06.046","article-title":"Juvenile polyarteritis: Results of a multicenter survey of 110 children","volume":"145","author":"Ozen","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0400","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jaad.2005.03.065","article-title":"Cutaneous polyarteritis nodosa in children","volume":"53","author":"Fathalla","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0405","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.autrev.2016.02.015","article-title":"Polyarteritis nodosa: A contemporary overview","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0410","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaut.2014.01.029","article-title":"Diagnosis and classification of polyarteritis nodosa","volume":"48-49","author":"Hernandez-Rodriguez","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0415","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/rheumatology\/36.8.909","article-title":"Long-term follow-up of juvenile-onset cutaneous polyarteritis nodosa associated with streptococcal infection","volume":"36","author":"Till","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0420","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1046\/j.1365-4362.1998.00493.x","article-title":"Relapsing cutaneous polyarteritis nodosa associated with streptococcal infections","volume":"37","author":"Albornoz","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0425","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.sder.2007.02.003","article-title":"Cutaneous polyarteritis nodosa","volume":"26","author":"Diaz-Perez","year":"2007","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0430","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0190-9622(94)70216-0","article-title":"Cutaneous polyarteritis nodosa of childhood","volume":"31","author":"Sheth","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0435","first-page":"767","article-title":"Intravenous immunoglobulin in childhood cutaneous polyarteritis nodosa","volume":"16","author":"Gedalia","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0440","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000051741","article-title":"Transient and partial effect of high-dose intravenous immunoglobulin in polyarteritis nodosa","volume":"203","author":"Kroiss","year":"2001","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0445","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-2133.1993.tb00276.x","article-title":"Successful treatment of cutaneous PAN with pentoxifylline","volume":"128","author":"Calderon","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0450","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/09546631003636809","article-title":"Ulcerative cutaneous polyarteritis nodosa treated with mycophenolate mofetil and pentoxifylline","volume":"22","author":"Kluger","year":"2011","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0455","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1525-1470.2011.01515.x","article-title":"Distal extremity necrosis as a manifestation of cutaneous polyarteritis nodosa: Case report and review of the acute management of a pediatric patient","volume":"29","author":"Williams","year":"2012","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0460","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/1529-0131(200103)44:3<508::AID-ANR96>3.0.CO;2-B","article-title":"Treatment of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: Where do we stand?","volume":"44","author":"Langford","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0465","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.rhu.0000173225.41933.83","article-title":"Successful treatment of childhood onset refractory polyarteritis nodosa with tumor necrosis factor alpha blockade","volume":"11","author":"Feinstein","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0470","first-page":"178","article-title":"Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children","volume":"16","author":"Kawasaki","year":"1967","journal-title":"Arerugi"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0475","doi-asserted-by":"crossref","first-page":"501.e501","DOI":"10.1016\/j.jaad.2013.06.040","article-title":"Kawasaki disease: Part I. Diagnosis, clinical features, and pathogenesis","volume":"69","author":"Bayers","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0480","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MD.0b013e3181df193c","article-title":"Kawasaki disease in adults: Report of 10 cases","volume":"89","author":"Gomard-Mennesson","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0485","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.hrtlng.2009.06.007","article-title":"Adult Kawasaki\u2019s disease with myocarditis, splenomegaly, and highly elevated serum ferritin levels","volume":"39","author":"Cunha","year":"2010","journal-title":"Heart Lung"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0490","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.annder.2008.06.012","article-title":"Adult Kawasaki disease","volume":"136","author":"Sbidian","year":"2009","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0495","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s11606-006-0100-5","article-title":"Acute Kawasaki disease: Not just for kids","volume":"22","author":"Wolff","year":"2007","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0500","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00124743-200106000-00013","article-title":"Kawasaki syndrome in an adult: Case report and review of the literature in adolescents and adults","volume":"7","author":"Kogulan","year":"2001","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0505","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/clc.4960090310","article-title":"Transient heart failure in an adult with Kawasaki disease","volume":"9","author":"Leclerc","year":"1986","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0510","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.semarthrit.2005.01.012","article-title":"Adult Kawasaki disease: Report of two cases and literature review","volume":"34","author":"Seve","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0515","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-4632.2004.02572.x","article-title":"Kawasaki disease in a US army soldier highlights surveillance","volume":"45","author":"Chang","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0520","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3349\/ymj.2012.53.2.262","article-title":"Kawasaki disease: Laboratory findings and an immunopathogenesis on the premise of a \u201cprotein homeostasis system.\u201d","volume":"53","author":"Lee","year":"2012","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0525","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.pcl.2012.03.009","article-title":"Kawasaki disease","volume":"59","author":"Scuccimarri","year":"2012","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0530","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1442-200X.2010.03178.x","article-title":"Epidemiological features of Kawasaki disease in Korea, 2006-2008","volume":"53","author":"Park","year":"2011","journal-title":"Pediatr Int"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0535","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2188\/jea.JE20090180","article-title":"Epidemiologic features of Kawasaki disease in Japan: Results of the 2007-2008 nationwide survey","volume":"20","author":"Nakamura","year":"2010","journal-title":"J Epidemiol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0540","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1542\/peds.2008-2187","article-title":"Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006","volume":"123","author":"Huang","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0545","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/INF.0b013e31825eaed0","article-title":"Perinatal exposures and Kawasaki disease in Washington State: A population-based, case-control study","volume":"31","author":"Hayward","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0550","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/INF.0b013e3181cf8705","article-title":"Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007","volume":"29","author":"Holman","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0555","first-page":"194","article-title":"Racial\/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii","volume":"69","author":"Holman","year":"2010","journal-title":"Hawaii Med J"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0560","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2165\/11631440-000000000-00000","article-title":"Epidemiology and management of Kawasaki disease","volume":"72","author":"Luca","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0565","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2188\/jea.JE20110131","article-title":"Epidemiology of Kawasaki disease in Asia, Europe, and the United States","volume":"22","author":"Uehara","year":"2012","journal-title":"J Epidemiol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0570","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0575","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s12098-011-0589-4","article-title":"Co-morbidity of Kawasaki disease","volume":"79","author":"Huang","year":"2012","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0580","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/428291","article-title":"Association between a novel human coronavirus and Kawasaki disease","volume":"191","author":"Esper","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0585","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/cid\/cis811","article-title":"Editorial commentary: Missing the forest for the trees: Respiratory viral assays in patients with kawasaki disease","volume":"56","author":"Rowley","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0590","first-page":"1350","article-title":"Kawasaki disease onset during concomitant infections with varicella zoster and Epstein-Barr virus","volume":"98","author":"Turkay","year":"2006","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0595","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00246-012-0223-x","article-title":"Single-nucleotide polymorphism rs2290692 in the 3\u2019UTR of ITPKC associated with susceptibility to Kawasaki disease in a Han Chinese population","volume":"33","author":"Peng","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0600","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCGENETICS.112.963710","article-title":"Genetics insights into the pathogenesis of Kawasaki disease","volume":"5","author":"Burns","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0605","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1253\/circj.CJ-12-0568","article-title":"Genetics of Kawasaki disease: What we know and don\u2019t know","volume":"76","author":"Onouchi","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0610","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0065-3101(23)00076-2","article-title":"Kawasaki disease","volume":"48","author":"Burns","year":"2001","journal-title":"Adv Pediatr"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0615","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/INF.0b013e31826108c2","article-title":"Infliximab treatment of pancreatitis complicating acute kawasaki disease","volume":"31","author":"Jimenez-Fernandez","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0620","doi-asserted-by":"crossref","first-page":"513.e511","DOI":"10.1016\/j.jaad.2013.06.040","article-title":"Kawasaki disease: Part II. Complications and treatment","volume":"69","author":"Bayers","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0625","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/01.CIR.94.6.1379","article-title":"Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients","volume":"94","author":"Kato","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0630","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02315475","article-title":"Coronary arterial lesions of Kawasaki disease: Cardiac catheterization findings of 1100 cases","volume":"7","author":"Suzuki","year":"1986","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0635","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1546-0096-10-28","article-title":"Catastrophic Kawasaki disease unresponsive to IVIG in a 3-month-old infant: A diagnostic and therapeutic challenge","volume":"10","author":"de Magalhaes","year":"2012","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0640","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pedneo.2011.11.003","article-title":"Kawasaki disease: An update on diagnosis and treatment","volume":"53","author":"Kuo","year":"2012","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0645","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/01.inf.0000134312.39744.a4","article-title":"Failure to diagnose Kawasaki disease at the extremes of the pediatric age range","volume":"23","author":"Pannaraj","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0650","first-page":"387","article-title":"Kawasaki disease in infants three months of age or younger","volume":"39","author":"Chuang","year":"2006","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0655","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-3476(95)70344-6","article-title":"Kawasaki disease in infants less than one year of age","volume":"126","author":"Rosenfeld","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0660","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1067\/mpd.2000.105150","article-title":"Kawasaki disease in older children and adolescents","volume":"137","author":"Stockheim","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0665","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1542\/peds.102.1.e7","article-title":"Kawasaki disease in the older child","volume":"102","author":"Momenah","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0670","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1542\/peds.2003-0118-F","article-title":"Older age is a risk factor for the development of cardiovascular sequelae in Kawasaki disease","volume":"114","author":"Muta","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0675","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s00246-012-0327-3","article-title":"Kawasaki disease: A rare case of diffuse coronary involvement","volume":"33","author":"Gupta","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0680","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00247-012-2478-z","article-title":"Acquired coronary disease in children: The role of multimodality imaging","volume":"43","author":"Ou","year":"2013","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0685","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1542\/peds.65.1.21","article-title":"National surveillance of Kawasaki disease","volume":"65","author":"Morens","year":"1980","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0690","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2188\/jea.13.246","article-title":"Analyses of fatal cases of Kawasaki disease in Japan using vital statistical data over 27 years","volume":"13","author":"Hayasaka","year":"2003","journal-title":"J Epidemiol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0695","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archpedi.156.2.162","article-title":"Mortality among persons with a history of Kawasaki disease in Japan: The fifth look","volume":"156","author":"Nakamura","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0700","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s00246-012-0186-y","article-title":"Incomplete and atypical Kawasaki disease: A clinicopathologic paradox at high risk of sudden and unexpected infant death","volume":"33","author":"Pucci","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0705","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1542\/peds.61.1.100","article-title":"Pathology of the heart in Kawasaki disease","volume":"61","author":"Fujiwara","year":"1978","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0710","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00246-010-9838-y","article-title":"The 30-year outcome for patients after myocardial infarction due to coronary artery lesions caused by Kawasaki disease","volume":"32","author":"Tsuda","year":"2011","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0715","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","article-title":"The treatment of Kawasaki syndrome with intravenous gamma globulin","volume":"315","author":"Newburger","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0720","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jpeds.2010.06.014","article-title":"Prospective open-label trial of etanercept as adjunctive therapy for kawasaki disease","volume":"157","author":"Choueiter","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0725","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpeds.2008.06.011","article-title":"Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease","volume":"153","author":"Burns","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.clindermatol.2017.08.004_bb0730","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/03009740600588228","article-title":"The effect of TNFalpha blockade in complicated, refractory Kawasaki disease","volume":"35","author":"Stenbog","year":"2006","journal-title":"Scand J Rheumatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X17301256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X17301256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:33:40Z","timestamp":1719362020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X17301256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":146,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0738081X17301256"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2017.08.004","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasculitis: Kids are not just little people","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2017.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}